30 years of the Czech National Marrow Donors Registry and the Bone Marrow Transplants Foundation

Czech version

Authors: P. Jindra ^1,2
Authors‘ workplace: Hematologicko-onkologické oddělení, FN Plzeň ¹; Český Národní Registr Dárců Dřeně, Plzeň ²
Published in: Transfuze Hematol. dnes,28, 2022, No. 4, p. 235-238.
Category: Letters to Editor

Sources

1. Jindra P. 25 let Českého národního registru dárců dřeně (ČNRDD) a Nadace pro transplantace kostní dřeně. Transfuze Hematol Dnes. 2017; 23 (4): 223–227.

2. Český národní registr dárců dřeně. Dostupné na https: //registr.kostnidren.cz/ (přístup dne 1.9.2022).

3. World Marrow Donor Association. Available at www.wmda.info (accessed on 1. Aug 2022).

4. Lown RN, Shaw BE. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant. 2013; 48: 210–219.

5. Pagel JM, Othus M, Garcia-Manero G, et al. Rapid donor identification improves survival in high-risk first-remission patients with acute myeloid leukemia. JCO Oncol Pract. 2020; 16 (6): e464–e475.

6. Collman C, Spellman SR, Zhang MJ, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016; 127: 260–267.

Labels

Haematology Internal medicine Clinical oncology

Tixagevimab-cilgavimab eff ectiveness in preexposure prophylaxis and therapy in patients at high risk of COVID-19

How do anti-SARS-CoV-2 IgG and IgM predict the titre of virus-neutralizing antibodies in donors of convalescent plasma against COVID-19 disease?

Current experience with ropeginterferon Alfa-2b in Ph negative myeloproliferative neoplasm at the Department of Internal Medicine – Haematology and Oncology in Brno

Haemolytic disease of the foetus and new-born

Beta-thalassemia minor and maior in pregnancy

Prof. MUDr. Karel Indrák, DrSc. se dožívá 75 let

Article was published in

Transfusion and Haematology Today

2022 Issue 4